MedTrace Logo

Clinical Outcome of Extended-depth-of-focus Trifocal Intraocualr Lens (Triumf) Implantation

NCT04392024 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2022-05-10

No results posted yet for this study

Summary

Clinical outcome of extended-depth-of-focus trifocal intraocualr lens (Triumf) implantation

Conditions

Interventions

DEVICE

Triumf

Triumf is intraocular lens which offers multifocal vision by extended depth of focus and diffractive optics.

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Tae-Young Chung, PhD · Samsung Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-29
Primary Completion
2022-01-22
Completion
2022-01-26

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04392024 on ClinicalTrials.gov